These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


67 related items for PubMed ID: 2501901

  • 1. Effect of the lupus anticoagulant on endothelial fibrinolytic activity in vitro.
    Francis RB, Neely S.
    Thromb Haemost; 1989 Apr 25; 61(2):314-7. PubMed ID: 2501901
    [Abstract] [Full Text] [Related]

  • 2. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB, McGehee WG, Feinstein DI.
    Thromb Haemost; 1988 Jun 16; 59(3):412-4. PubMed ID: 3142079
    [Abstract] [Full Text] [Related]

  • 3. Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant.
    Tsakiris DA, Marbet GA, Makris PE, Settas L, Duckert F.
    Thromb Haemost; 1989 Apr 25; 61(2):175-7. PubMed ID: 2501894
    [Abstract] [Full Text] [Related]

  • 4. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation.
    Cariou R, Tobelem G, Bellucci S, Soria J, Soria C, Maclouf J, Caen J.
    Thromb Haemost; 1988 Aug 30; 60(1):54-8. PubMed ID: 2847352
    [Abstract] [Full Text] [Related]

  • 5. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 6. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS, Wang C, Lu Y, Yang YH, Xing GH, Mao YL, Huang XX, Zhai ZG.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 20; 87(43):3074-8. PubMed ID: 18261355
    [Abstract] [Full Text] [Related]

  • 7. Cathepsin G--induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes?
    Pintucci G, Iacoviello L, Castelli MP, Amore C, Evangelista V, Cerletti C, Donati MB.
    J Lab Clin Med; 1993 Jul 20; 122(1):69-79. PubMed ID: 8320493
    [Abstract] [Full Text] [Related]

  • 8. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H, Hagiya Y, Ueshima S, Okada K, Takaishi T, Izaki S, Matsuo O.
    Thromb Haemost; 1996 Feb 20; 75(2):352-8. PubMed ID: 8815589
    [Abstract] [Full Text] [Related]

  • 9. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
    Orbe J, Chordá C, Montes R, Páramo JA.
    Haematologica; 1999 Apr 20; 84(4):306-11. PubMed ID: 10190943
    [Abstract] [Full Text] [Related]

  • 10. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J, Delarue F, Peraldi MN, Sraer JD, Rondeau E.
    Lab Invest; 1994 Dec 20; 71(6):828-37. PubMed ID: 7807964
    [Abstract] [Full Text] [Related]

  • 11. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
    Tabengwa EM, Grenett HE, Benza RL, Abou-Agag LH, Tresnak JK, Wheeler CG, Booyse FM.
    Alcohol Clin Exp Res; 2001 Feb 20; 25(2):163-70. PubMed ID: 11236828
    [Abstract] [Full Text] [Related]

  • 12. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
    Colucci M, Gesualdo L, Montemurro P, Cavallo LG, Conese M, Mascolo E, Ranieri E, Di Paolo S, Schena FP, Semeraro N.
    Thromb Haemost; 1995 Dec 20; 74(6):1516-20. PubMed ID: 8772230
    [Abstract] [Full Text] [Related]

  • 13. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.
    Sultan Y, Harris A, Strauch G, Venot A, De Lauture D.
    J Lab Clin Med; 1988 Jun 20; 111(6):645-53. PubMed ID: 3131470
    [Abstract] [Full Text] [Related]

  • 14. [Tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI)].
    Hayashi T.
    Rinsho Byori; 1994 Apr 20; 42(4):346-51. PubMed ID: 8176842
    [Abstract] [Full Text] [Related]

  • 15. Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.
    Matsuno H, Kozawa O, Niwa M, Ueshima S, Matsuo O, Collen D, Uematsu T.
    Thromb Haemost; 1999 Apr 20; 81(4):601-4. PubMed ID: 10235447
    [Abstract] [Full Text] [Related]

  • 16. Treatment with hyperbaric oxygen affects endothelial cell fibrinolysis.
    Tjärnström J, Holmdahl L, Arnell P, Falkenberg M, Risberg B.
    Eur J Surg; 1999 Sep 20; 165(9):834-8. PubMed ID: 10533756
    [Abstract] [Full Text] [Related]

  • 17. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM, Stephens CJ, Black MM, Hunt BJ.
    Clin Exp Dermatol; 1996 Jan 20; 21(1):28-32. PubMed ID: 8689765
    [Abstract] [Full Text] [Related]

  • 18. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Jan 20; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 19. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G, Hauert J, Kruithof EK, Van Melle G, Bachmann F.
    Thromb Haemost; 1988 Apr 08; 59(2):299-303. PubMed ID: 3133812
    [Abstract] [Full Text] [Related]

  • 20. [Effect of shear stress on hemostatic regulation in endothelium].
    Kawai Y, Matsumoto Y, Ikeda Y, Yamamoto H, Satoh K, Watanabe K.
    Rinsho Byori; 1994 Nov 08; 42(11):1128-36. PubMed ID: 7844884
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.